| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |